• Wednesday, Sep 30, 2020
  • Last Update : 12:40 pm

Brazil state signs deal to make Russian vaccine

  • Published at 07:31 pm August 13th, 2020
Russia's new coronavirus vaccine
The Brazilian state of Parana has signed a deal to test and produce Russia's new coronavirus vaccine, though officials stressed they would have to be sure of its safety and effectiveness first Twitter

The vaccine would have to receive Brazilian regulatory approval and complete Phase 3 clinical trials, or large-scale testing in humans

The Brazilian state of Parana signed a deal Wednesday to test and produce Russia's new coronavirus vaccine, though officials stressed they would have to be sure of its safety and effectiveness first.

The vaccine would have to receive Brazilian regulatory approval and complete Phase 3 clinical trials, or large-scale testing in humans, before being produced in Brazil, said officials from the southern state.

Production, if it goes ahead, would likely only start in the second half of 2021, said Jorge Callado, head of the state-run Parana Technology Institute, which signed the deal with the Russian Direct Investment Fund (RDIF).

"This is a very objective memorandum of understanding on technological exchange. It does not impose obligations, it simply enables us to work together," he told a virtual news conference.

He said that under the deal Russia would share the results of Phase 1 and 2 testing with the state.

President Vladimir Putin announced Tuesday that Russia had approved the vaccine, dubbed "Sputnik V," in a world first, heralding it as a game-changer in the pandemic.

But international health officials have cautioned more testing and scrutiny are needed to ensure it is safe and effective.

Brazil has become a popular testing ground for Covid-19 vaccines, since the new coronavirus is still spreading quickly there.

The country has the second-highest number of infections and deaths in the pandemic, after the United States: more than 3.1 million and 104,000, respectively.

Two experimental vaccines are currently in Phase 3 testing in Brazil, one developed by Oxford University with pharmaceutical firm AstraZeneca and the other by Chinese laboratory Sinovac Biotech.

50
50
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail